Management of Pediatric Generalized Pustular Psoriasis Using Biologics: An Evidence-Based Review

Published: 18 October 2021| Version 1 | DOI: 10.17632/k36mry2nk6.1
Contributor:
Muskaan Sachdeva

Description

Generalized pustular psoriasis (GPP) is a rare autoinflammatory condition that often presents diagnostic and therapeutic challenges.1 It has been linked to a deficiency of the interleukin-36 receptor 76 antagonist (DITRA). Currently, there are no universally-accepted, standardized, evidence-based 77 management guidelines. The purpose of this systematic review was to examine biologic use in pediatric 78 patients with GPP.

Files

Categories

Pediatrics, Systematic Review, Psoriasis

License